Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$10.87 USD
-0.24 (-2.16%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $10.88 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for Dynavax Technologies Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 742 | 624 | 546 | 165 | 151 |
Receivables | 45 | 148 | 132 | 23 | 9 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 53 | 59 | 61 | 64 | 41 |
Other Current Assets | 19 | 86 | 233 | 39 | 7 |
Total Current Assets | 859 | 917 | 973 | 290 | 209 |
Net Property & Equipment | 37 | 38 | 35 | 31 | 32 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2 | 2 | 2 | 2 | 5 |
Deposits & Other Assets | 74 | 4 | 4 | 4 | 4 |
Total Assets | 997 | 986 | 1,039 | 353 | 279 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 3 | 3 | 3 | 9 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 52 | 35 | 54 | 22 | 19 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5 | 111 | 499 | 52 | 25 |
Total Current Liabilities | 62 | 150 | 556 | 77 | 53 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 223 | 222 | 220 | 0 | 0 |
Long-Term Debt | 30 | 0 | 0 | 180 | 179 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 60 | 0 | 6 | 3 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 375 | 405 | 817 | 295 | 271 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,555 | 1,511 | 1,442 | 1,352 | 1,229 |
Retained Earnings | -931 | -924 | -1,217 | -1,294 | -1,219 |
Other Equity | -2 | -5 | -2 | 0 | -2 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 622 | 581 | 222 | 59 | 8 |
Total Liabilities & Shareholder's Equity | 997 | 986 | 1,039 | 353 | 279 |
Total Common Equity | 622 | 581 | 222 | 59 | 8 |
Shares Outstanding | 129.20 | 127.50 | 119.90 | 110.10 | 83.80 |
Book Value Per Share | 4.81 | 4.56 | 1.85 | 0.53 | 0.10 |
Fiscal Year End for Dynavax Technologies Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 736 | 724 | 742 | 720 | 682 |
Receivables | 63 | 46 | 45 | 47 | 45 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 62 | 62 | 53 | 49 | 53 |
Other Current Assets | 21 | 20 | 19 | 19 | 17 |
Total Current Assets | 882 | 851 | 859 | 836 | 797 |
Net Property & Equipment | 36 | 36 | 37 | 36 | 37 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2 | 2 | 2 | 2 | 2 |
Deposits & Other Assets | 74 | 73 | 74 | 74 | 74 |
Total Assets | 1,016 | 987 | 997 | 973 | 936 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 2 | 5 | 3 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 53 | 49 | 52 | 47 | 37 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5 | 5 | 5 | 4 | 4 |
Total Current Liabilities | 62 | 56 | 62 | 54 | 45 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 223 | 223 | 223 | 222 | 222 |
Long-Term Debt | 0 | 0 | 30 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 61 | 60 | 61 | 61 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 373 | 368 | 375 | 368 | 359 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,576 | 1,562 | 1,555 | 1,542 | 1,528 |
Retained Earnings | -928 | -939 | -931 | -931 | -945 |
Other Equity | -5 | -4 | -2 | -6 | -5 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 643 | 618 | 622 | 605 | 577 |
Total Liabilities & Shareholder's Equity | 1,016 | 987 | 997 | 973 | 936 |
Total Common Equity | 643 | 618 | 622 | 605 | 577 |
Shares Outstanding | 130.80 | 130.80 | 129.20 | 128.80 | 127.70 |
Book Value Per Share | 4.91 | 4.73 | 4.81 | 4.70 | 4.52 |